| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 37 |
| 1 | LEVONORGESTREL | 34 |
| 2 | ERGOCALCIFEROL | 25 |
| 3 | ETANERCEPT | 25 |
| 4 | ACETAMINOPHEN | 20 |
| 5 | LEVOTHYROXINE SODIUM | 20 |
| 6 | INTERFERON BETA-1A | 18 |
| 7 | IRON | 17 |
| 8 | METHOTREXATE SODIUM | 17 |
| 9 | PREDNISONE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZOCAINE AND CHLOROXYLENOL | 1 | 0.0222 |
| 1 | HOMOSALATE, OCTISALATE, AVOBENZONE, AND DIMETHICONE | 1 | 0.0217 |
| 2 | FOSTEMSAVIR TROMETHAMINE | 1 | 0.0041 |
| 3 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0040 |
| 4 | BENZOCAINE AND MENTHOL | 1 | 0.0038 |
| 5 | THROMBIN HUMAN AND FIBRINOGEN | 1 | 0.0030 |
| 6 | SEGESTERONE ACETATE AND ETHINYL ESTRADIOL | 1 | 0.0026 |
| 7 | LUMASIRAN | 1 | 0.0026 |
| 8 | IBALIZUMAB | 1 | 0.0019 |
| 9 | PASIREOTIDE | 4 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 50 |
| 1 | Corticosteroid [EPC] | 42 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 37 |
| 3 | Progestin [EPC] | 37 |
| 4 | Progestin-containing Intrauterine System [EPC] | 34 |
| 5 | Benzodiazepine [EPC] | 30 |
| 6 | Provitamin D2 Compound [EPC] | 25 |
| 7 | Aromatase Inhibitor [EPC] | 19 |
| 8 | Interferon beta [EPC] | 19 |
| 9 | Kinase Inhibitor [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Progestin Antagonist [EPC] | 6 | 0.0013 |
| 3 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 4 | Ergot Derivative [EPC] | 5 | 0.0010 |
| 5 | Provitamin D2 Compound [EPC] | 25 | 0.0008 |
| 6 | Somatostatin Analog [EPC] | 5 | 0.0007 |
| 7 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 8 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 9 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |